Global Angioplasty Balloons Market Forecast (2018-2025) Report: By Regions, Type and Application with Sales and Revenue Analysis

By fiormarkets |Email | Jan 30, 2019 | 3597 Views

The global angioplasty balloons market is expected to grow from USD 2,131.34 Million in 2017 to USD 2,834.53 Million by 2025 at a CAGR of 3.61% during the forecast period from 2018-2025. North America market held the largest market share and is expected to witness significant growth over the next decade. This growth can be attributed to rising cases of cardiovascular and lifestyle-associated disorders and high adoption rate of novel technologies are some of the factors that led to the growth of angioplasty balloons market in this region.

Global Angioplasty Balloons Market by Product Type (Normal Balloon Catheter, Drug-Eluting Balloons, Cutting Balloon Catheter, Scoring Balloon Catheter), Material, Application, End User, Regionâ?? and Global Forecast 2018-2025.

Major market players in the industry include Boston Scientific Corporation, Medtronic PLC, Abbott Inc., Johnson & Johnson, C.R. Bard Inc, Spectranetics, Cardinal Health Inc., BIOTRONIK SE & Co.KG, Cook Medical Inc, ENDOCOR GmbH, B. Braun Melsungen AG, Terumo Corporation, Koninklijke Philips, Covidien, Cordis Corporation, Thomas Medical, Inc.among others. Major market players are estimated to augment the market during the forecast years through partnerships or collaborations and product and technological developments. For instance, in 2014, Medtronic PLC launched its drug-coated balloon IN.PACT Admiral for the treatment of peripheral artery disease. In 2018, Cagent vascular expanded its serranator family of percutaneous transluminal angioplasty (PTA) serration balloon catheters. This is intended to expand balloon catheters product range.

The type segment is classified into normal balloon catheter, drug-eluting balloons, cutting balloon catheter, scoring balloon catheter. Drug-eluting balloons (DEBs) is expected to be the fastest-growing type segment with the highest CAGR of 5.86% in the forecast period. New product launch, advantages over the standard balloon and low cost as compared to conventional stents, these are the key factors to drive the demand of the segment. Material segment is divided into non-compliant material and semi-compliant material. Application segment is divided into peripheral and coronary. Coronary segment is playing a chief role in shaping business growth. The end user segment includes ambulatory surgery centers (ascs), hospitals and catheterization laboratories. Ambulatory surgery centers held the largest share of 36.28% in 2017 owing to huge demand for the treatments in these settings.

DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report/global-angioplasty-balloons-market-by-product-type-normal-362193.html#sample

Angioplasty is a minimally invasive procedure hence preferred by surgeons over high-cost stent placements is a major factor driving the market. In addition, adoption of advanced technologies are fuelling the growth of market. Reimbursement issues and alternatives choices like bypass surgery, the risk of infection may hamper the growth of market. However, technological advancements, increasing incidences of peripheral vascular diseases and increasing R&D are expected to boost the market in coming years.

Customization of the Report:
This report can be customized to meet the clientâ??s requirements. Please connect with our sales team (sales@fiormarkets.com), who will ensure that you get a report that suits your needs.

Source: https://www.fiormarkets.com/report/global-angioplasty-balloons-market-by-product-type-normal-362193.html